/Tebao Biotechnology: Announcement on the repurchase of the company's shares reaching 2% through centralized bidding transactions and the progress of the repurchase
NEWS

Tebao Biotechnology: Announcement on the repurchase of the company's shares reaching 2% through centralized bidding transactions and the progress of the repurchase

Shanghai Stock Exchange
2026/06/18

Securities code: 688278 Securities abbreviation: Tebao Biotechnology Announcement number: 2026-052

Xiamen Tebao Bioengineering Co., Ltd.

Regarding the repurchase of the company's shares through centralized bidding transactions, the proportion of the company's shares reached

2%

Announcement on the progress of buyback

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.

Important content reminder:

The first disclosure date of the repurchase plan is 2026/5/12, proposed by the company’s board of directors

The implementation period of the buyback plan is from May 12, 2026 to May 11, 2027

The estimated repurchase amount is 300 million yuan to 500 million yuan

□Reduce registered capital

√Used for employee stock ownership plans or equity incentives

Repurchase purpose

√ Used to convert company convertible bonds

□To protect the company’s value and shareholders’ rights and interests

The cumulative number of shares repurchased is 5,701,358 shares

The cumulative number of repurchased shares accounts for 1.40% of the total share capital

The cumulative repurchased amount is 316.1403 million yuan

Actual repurchase price range: 53.44 yuan/share ~ 57.20 yuan/share

Note: The above table contains the repurchase progress of Xiamen Tebao Bioengineering Co., Ltd. (hereinafter referred to as the "Company")'s second repurchase plan in 2026. The company's first share repurchase plan in 2026 was completed on May 8, 2026. A total of 3,439,625 shares of the company were repurchased, and the total repurchase funds were RMB 199,968,197.77 (excluding transaction costs such as stamp duty and transaction commissions). For details, please refer to the "Announcement on the Progress and Implementation Results of Share Repurchases and Changes in Shares" disclosed by the company on the website of the Shanghai Stock Exchange (www.sse.com.cn) on May 9, 2026 (announcement number: 2026-042).

1. Basic information on share repurchase

(1) The first share repurchase plan in 2026

The company held the 17th meeting of the ninth board of directors on March 26, 2026 and the 2026 meeting on April 13, 2026 respectively. The second extraordinary shareholders' meeting in 2019 reviewed and approved the "Proposal on the Plan to Repurchase the Company's Shares through Centralized Bidding Transactions", agreeing that the company will use its own funds and self-raised funds (including special loan funds for stock repurchases, etc.) to repurchase some of the company's issued ordinary RMB shares (A shares) through centralized bidding transactions, and use them for employee stock ownership plans and/or equity incentives at an appropriate time in the future, or for converting corporate bonds issued by the company that can be converted into stocks. The total amount of repurchase funds shall not be less than RMB 10,000. Ten thousand yuan (inclusive), not exceeding RMB 200 million (inclusive), the repurchase price not exceeding RMB 85 per share (inclusive), and the repurchase period shall be within 12 months from the date the company's shareholders meeting approves the share repurchase plan. The company's first share repurchase plan in 2026 was completed on May 8, 2026. A total of 3,439,625 shares of the company were repurchased, and the total repurchase funds were RMB 199,968,197.77 (excluding transaction costs such as stamp duty and transaction commissions).

For details, please refer to the company’s announcements on March 27, 2026, April 14, 2026, and The "Plan on the Repurchase of Shares through Centralized Bidding Transactions" (Announcement No.: 2026-018), the "Repurchase Report on the Repurchase of Shares through Centralized Bidding Transactions" (Announcement No.: 2026-032), and the "Announcement on the Progress and Implementation Results of Share Repurchases and Changes in Shares" (Announcement No.: 2026-042) were disclosed on the Shanghai Stock Exchange website (www.sse.com.cn) on May 9.

(2) Second share repurchase plan in 2026

Company in 2026 The 20th meeting of the ninth board of directors was held on May 11, 2018, and the "Proposal on the Plan for Repurchasing the Company's Shares through Centralized Bidding Transactions" was reviewed and approved. It was agreed that the company would use its own funds and self-raised funds (including special loan funds for stock repurchases, etc.) to repurchase some of the issued RMB ordinary shares (A shares) through centralized bidding transactions, and use them to implement employee stock ownership plans and/or equity incentives at an appropriate time in the future, or to convert corporate bonds issued by the company that can be converted into stocks. The total amount of repurchase funds shall not be less than RMB. 300 million yuan (inclusive), not exceeding RMB 500 million (inclusive), the repurchase price not exceeding RMB 85 per share (inclusive), and the repurchase period shall be within 12 months from the date the company's board of directors considers and approves the share repurchase plan. For details, please refer to the "Repurchase Plan and Repurchase Report on Shares through Centralized Bidding Transactions" disclosed by the company on the Shanghai Stock Exchange website (www.sse.com.cn) on May 12, 2026 (Announcement Number: 2026-044).

Due to the company's implementation of the 2025 annual equity distribution, the upper limit of the share repurchase price will be adjusted from no more than RMB 85 per share (inclusive) to no more than RMB 84.39 per share (inclusive) starting from May 29, 2026 (the ex-rights and ex-dividend date of the 2025 annual equity distribution). For details, please refer to the "Announcement on Adjusting the Price Cap for Repurchased Shares after the Implementation of the Annual Equity Distribution in 2025" disclosed by the company on the Shanghai Stock Exchange website (www.sse.com.cn) on May 30, 2026 (Announcement No.: 2026-048).

2. Progress of share repurchase

According to the relevant provisions of the "Share Repurchase Rules for Listed Companies" and "Shanghai Stock Exchange Self-Regulatory Supervision Guidelines for Listed Companies No. 7 - Repurchase of Shares", during the period of repurchase of shares, for every 1% increase in the proportion of repurchased shares in the company's total share capital, the company shall disclose it within 3 trading days from the date of the fact. The company’s repurchase progress is now announced as follows:

The company is implementing the second share repurchase plan in 2026. As of June 17, 2026, the second share repurchase plan has repurchased a total of 5,701,358 shares of the company. The highest price of the repurchase transaction was 57.20 yuan/share, and the lowest price was 53.44 yuan/share. The total amount of funds paid was RMB 316,140,335.30. Yuan (excluding stamp duty, transaction commission and other transaction costs).

As of June 17, 2026, the company's first and second share repurchase plans in 2026 have repurchased a total of 9,140,983 shares of the company through centralized bidding transactions through the Shanghai Stock Exchange trading system, accounting for 2.24% of the company's total share capital, an increase of 1.14% compared to the previous disclosure of 1%.

The above-mentioned share repurchase complies with the provisions of relevant laws and regulations and the requirements of the company's share repurchase plan.

3. Other matters

The company will strictly abide by the "Share Repurchase Rules for Listed Companies", "Shanghai Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 7 - Repurchase of Shares" and other relevant regulations, make repurchase decisions based on market conditions during the repurchase period and implement them, and at the same time perform information disclosure obligations in a timely manner based on the progress of the share repurchase matter. Investors are kindly requested to pay attention to investment risks.

Announcement is hereby made.

Board of Directors of Xiamen Tebao Bioengineering Co., Ltd.

June 18, 2026